Humoral Immune Responses to EGFR-Derived Peptides Predict Progression-Free and Overall Survival of Non-Small Cell Lung Cancer Patients Receiving Gefitinib

Somatic mutations in the epidermal growth factor receptor (EGFR) gene are associated with clinical response to EGFR tyrosine kinase inhibitors (TKIs), such as gefitinib, in patients with non-small cell lung cancer (NSCLC). However, humoral immune responses to EGFR in NSCLC patients have not been wel...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Azuma, Koichi, Komatsu, Nobukazu, Hattori, Satoshi, Matsueda, Satoko, Kawahara, Akihiko, Sasada, Tetsuro, Itoh, Kyogo, Hoshino, Tomoaki
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3909003/
https://ncbi.nlm.nih.gov/pubmed/24497964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0086667
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados